• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Women’s Reproductive Healthcare in Asia Gets Boost with First At-Home Blood-Testing Kit for Female Fertility

Share:

February 3, 2021

Women can now get their fertility tested from the comfort of home, whilst also getting further insight into their general health.

Health start-up Yesmom has launched Asia’s first at-home blood testing kits for female fertility, designed to help women stay on the front foot of their reproductive health from the comfort of home.

Through a simple finger-prick, the blood testing kit, which is ordered online and delivered, allows women to receive results on their reproductive health within a few days upon mailing out of the sample – via an online dashboard that provides clear, comprehensive, and clinical-grade insights.

HOW IT WORKS

By examining the six fertility hormones Anti-Mullerian Hormone (AMH), Follicle Stimulating Hormone (FSH), Thyroid Stimulating Hormone (TSH), Free Thyroxine (ft4), Prolactin (PRL), and Testosterone (TT), Yesmom’s kit shows how hormone levels can affect egg freezing or IVF, screens for thyroid dysfunction that could negatively impact conception, and flags anything that could affect normal ovulation and the fertility window. It also enables women to learn more about menopause and make informed decisions on their reproductive future.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

The test can also indicate whether a woman may have Polycystic Ovary Syndrome (PCOS), a condition that affects up to 20% of women, often undiagnosed, and is a leading cause of infertility.

ON THE RECORD

“Hormone testing is a great way to keep track of your overall health. The benefit of spotting and treating conditions like PCOS early on is that it can prevent further complications. These include diabetes, blood pressure abnormalities, and even life-threatening conditions like heart disease and cancer,” says Yesmom Fertility’s Medical Advisor Dr. Olarik Musavigong.

“Women everywhere should have the option to be proactive about their reproductive healthcare,” ADDED Yesmom CEO Peter Macquart-Moulin. “While lab testing for fertility in Asia remains inaccessible to most consumers due to cost and confusing outcomes, we’ve developed an accessible, affordable at-home fertility testing kit that’s easy to use and provides quick results that are simple to understand.”

The test kits are currently available in India and Thailand with further expansion across SE Asia expected before the end of the year.

Source: Mobihealth News

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Yale, Sharecare Partner For an Online Physician Assistant Curriculum, CoxHealth Adopts MDLive’s Platform and More Digital Health DealsYale, Sharecare Partner For an Online Physician Assistant Curriculum, CoxHealth Adopts MDLive’s Platform and More Digital Health Deals
  • AbbVie, Tolero team up to test Venclexta combo in AMLAbbVie, Tolero team up to test Venclexta combo in AML
  • Aditxt Signs a Transaction Agreement to Acquire Aipharma, Rights Holder of Antiviral Tablet Avigan/reeqonus/qifenda Used in the Treatment of Over 1.5 Million Covid-19 Patients Outside the U.s. and CanadaAditxt Signs a Transaction Agreement to Acquire Aipharma, Rights Holder of Antiviral Tablet Avigan/reeqonus/qifenda Used in the Treatment of Over 1.5 Million Covid-19 Patients Outside the U.s. and Canada
  • CTA Launches First-Ever Ansi-Accredited Standard for AI in HealthcareCTA Launches First-Ever Ansi-Accredited Standard for AI in Healthcare
  • OrthoPediatrics Corp. Completes Acquisition of Pega MedicalOrthoPediatrics Corp. Completes Acquisition of Pega Medical
  • With Anti-CD47 Cancer Drugs Trending, Arch Takes in $105 Million for Its AntibodyWith Anti-CD47 Cancer Drugs Trending, Arch Takes in $105 Million for Its Antibody
  • Lilly’s Targeted RET Drug Shrinks Tumors In Lung Cancer TrialLilly’s Targeted RET Drug Shrinks Tumors In Lung Cancer Trial
  • Insights on Lip Fillers Market: Facts, Figures and Trends 2020-2026Insights on Lip Fillers Market: Facts, Figures and Trends 2020-2026

Trending This Week

  • Treehill Partners’ Ali Pashazadeh on How to Improve Clinical Trial Design
  • M&A and investing activity in the Indian healthcare sector has been strong
  • AI-Powered Approach for Personalized Heart Disease Care
  • Clinical Trial Data Strategy: Shifting to Innovative Data Collection and Flow While Reducing Burden On Your Sites
  • AstraZeneca Forms Health Tech Business, Evinova to Deliver Digital Health Solutions for Life Sciences
  • Memorial Hermann Health System, AI-enabled Laudio partner for frontline leaders

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications